Skip to content
Home / News |

Tempus AI Stock (NASDAQ: TEM) Down 20% From Highs Leading Into Earnings

Tempus AI’s stock (NASDAQ: TEM) has been a significant outperformer on the index this year, despite a recent 20% pullback from highs. When accounting for the past few days’ correction, the stock price remains an impressive 108% up YTD.

This significant rally was influenced by positive market sentiment and pivotal announcements regarding Tempus’ advancements in artificial intelligence driven healthcare technology, primarily motivated by the introduction of a new AI-enabled health application, Olivia.

The application is designed to serve as a personal health concierge service, aiming to centralise health records while providing AI-generated insights. Olivia features a Smart Profile Summary and an AI-enabled Notetaker, enhancing patient engagement and experience.

WELCOME BONUS - Free Share Bundle When You Invest £50! Open a UK Investment Account: Shares, ISAs, Managed Portfolio Invest in 15,000+ shares and ETFs. Open an account now, invest at least £50, and you’ll get a free share bundle worth between £40 and £200. T&Cs apply. IG
5.0
View Offers
Empfohlener Broker Multi Asset Platform
Social-Trading-Pionier mit Aktien, ETFs, Krypto und CFDs, Copy Trading inklusive. eToro
5.0
Weitere Informationen 50% of retail investor accounts lose money when trading CFDs with this provider.

Eric Lefkofsky, founder and CEO of Tempus, highlighted the potential of Olivia in empowering patients for better health management. The announcement of the app notably contributed to the upward movement in Tempus’ stock price, reinforcing its role as a leader in healthcare innovation.

Market analysts have continued to support the stock, but the pace of appreciation has caught most behind, with the consensus target of $58.60 now clearly down on the current price action ~$71.50.

With earnings looming on Monday 24th Feb, Tempus has the opportunity to offer up some concrete numbers. The previous quarter’s revenue came in at $180.93 million, a beat on the $179.56 expected. Nonetheless, the company recorded a net loss with an EPS of -$0.25, itself an outperformance on the -$0.28 expected.

Looking forward to Monday’s earnings, and markets are expecting Tempus to come in with an EPS of -$0.15, against revenue of $202.80. After such a rally, anything less than a firm beat and raise may be harshly treated.

Searching for the Perfect Broker?

Discover our top-recommended brokers for trading or investing in financial markets. Dive in and test their capabilities with complimentary demo accounts today!

YOUR CAPITAL IS AT RISK. 76% OF RETAIL CFD ACCOUNTS LOSE MONEY

Asktraders News Team
Team Member

The AskTraders Analyst Team features experts in technical and fundamental analysis, as well as traders specializing in stocks, forex, and cryptocurrency.